Precursor-dependent indirect pharmacodynamic response model for tolerance and rebound phenomena.
暂无分享,去创建一个
W J Jusko | W F Ebling | W. Jusko | W. Ebling | A Sharma | A. Sharma | Amarnath Sharma | William J. Jusko
[1] Perry,et al. Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. , 1980, The Journal of clinical investigation.
[2] David R. Sibley,et al. Molecular mechanisms of receptor desensitization using the β-adrenergic receptor-coupled adenylate cyclase system as a model , 1985, Nature.
[3] S. Gottlieb,et al. Prevention and reversal of nitrate tolerance in patients with congestive heart failure. , 1987, The New England journal of medicine.
[4] M. Houston,et al. Beta-adrenergic blocker withdrawal syndromes in hypertension and other cardiovascular diseases. , 1988, American heart journal.
[5] A. Guyton,et al. Blood pressure control--special role of the kidneys and body fluids. , 1991, Science.
[6] W J Jusko,et al. Transit compartments versus gamma distribution function to model signal transduction processes in pharmacodynamics. , 1998, Journal of pharmaceutical sciences.
[7] E. Ekblad,et al. A model eliciting transient responses. , 1984, The American journal of physiology.
[8] Johan Gabrielsson,et al. Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration , 1996, Clinical pharmacology and therapeutics.
[9] A Schumitzky,et al. A program package for simulation and parameter estimation in pharmacokinetic systems. , 1979, Computer programs in biomedicine.
[10] J. Mandema,et al. Pharmacodynamic model for acute tolerance development to the electroencephalographic effects of alfentanil in the rat. , 1995, The Journal of pharmacology and experimental therapeutics.
[11] M. Hammarlund-Udenaes,et al. Prolactin release after remoxipride by an integrated pharmacokinetic-pharmacodynamic model with intra- and interindividual aspects. , 1995, The Journal of pharmacology and experimental therapeutics.
[12] W J Jusko,et al. Integrated functions for four basic models of indirect pharmacodynamic response. , 1998, Journal of pharmaceutical sciences.